Profiel
Cheryl A. Madsen is currently the Senior Vice President-Regulatory Affairs at Viracta Therapeutics, Inc. She previously worked as the Senior Director at Medivation, Inc., Vice President-Regulatory Affairs at Peloton Therapeutics, Inc., and Vice President-Regulatory Affairs at Calithera Biosciences, Inc. She obtained her undergraduate degree from the University of California, Santa Cruz.
Actieve functies van Cheryl A. Madsen
| Bedrijven | Functie | Begin |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Algemeen Adviseur | - |
Eerdere bekende functies van Cheryl A. Madsen
| Bedrijven | Functie | Einde |
|---|---|---|
| PELOTON THERAPEUTICS, INC. | Algemeen Adviseur | - |
Medivation, Inc. /Old/
Medivation, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Corporate Officer/Principal | - |
| CALITHERA BIOSCIENCES, INC. | Algemeen Adviseur | - |
Opleiding van Cheryl A. Madsen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Peloton Therapeutics, Inc.
Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Medivation, Inc. /Old/
Medivation, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
University of California, Santa Cruz
University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calithera Biosciences, Inc.
Calithera Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics to control cancer and other diseases | Health Technology |
Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
















